BioSpace News Archive

Career Advice

Grace Under Fire: How to Respond to Tough Job Interview Questions

It’s one of the biggest sources of anxiety when you’re on the job market: being faced with tough interview questions that you aren’t quite sure how to answer.

October 22, 2018
·
3 min read
·
Editorial Staff
Drug Development

Updated with Exclusive | ESMO 2018: 60% of Ovarian Cancer Patients Receiving Lynparza Were Progression-Free at 3 Years

AstraZeneca and Merck & Co. presented results at the Presidential Symposium at the European Society for Medical Oncology 2018 Congress held in Munich Germany describing its Phase III SOLO-1 trial of Lynparza (olaparib) in ovarian cancer.

October 22, 2018
·
4 min read
·
Mark Terry
Business

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer

Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer.

October 22, 2018
·
5 min read
Business

With Goals to Combat Antibiotic Resistance, Qpex Biopharma Launches with $33M

Qpex Biopharma, a company spun-out of The Medicines Company focused on the development of anti-infective assets, launched this morning supported by a $33 million Series A financing round and a BARDA contract worth up to $132 million.

October 22, 2018
·
2 min read
·
Alex Keown
Biotech Bay

Synthego Snags $110 Million in Series C to Advance Vision of Making CRISPR Technology More Available

Genome engineering company Synthego received an infusion of $110 million from a Series C financing round led by Peter Thiel’s Founders Fund. The funds will be used to accelerate the company’s vision to make CRISPR technology more accessible to researchers.

October 22, 2018
·
3 min read
·
Alex Keown
Pharm Country

Healthy Lung Month: Emerging Treatment Options for Mesothelioma Patients

Mesothelioma is a rare cancer that develops in the lining of the lungs, abdomen, or cardiovascular cavity. A 2017 study reported that the number of people affected by this rare cancer is between 2,400 - 2,800 individuals per year in the United States alone.

October 22, 2018
·
7 min read
·
Emily Walsh, Mesothelioma Cancer Alliance
Drug Development

Auris Medical Announces Positive Results From Second Phase 1 Clinical Trial With Intranasal Betahistine

Bioavailability significantly higher than with oral administration

October 22, 2018
·
6 min read
Business

Department of Defense Amyotrophic Lateral Sclerosis Research Program

Anticipated Funding Opportunities for Fiscal Year 2019 (FY19)

October 22, 2018
·
4 min read
Oventus Medical Ltd (ASX:OVN) New Clinical Trial Data Demonstrates Sleep Treatment Platform Delivers Significantly Improved Treatment Outcomes for OSA Sufferers

Oventus Medical Ltd is pleased to announce that new clinical data from four separate studies on its Sleep Treatment Platform will be presented at Sleep DownUnder, the 30th annual meeting of sleep specialists, taking place in Brisbane between 17th -20th October.

October 22, 2018
·
3 min read
Drug Development

Here’s What Happened at ESMO 2018 This Weekend: Novartis, Pfizer, and More

The European Society of Medical Oncology was in full swing this weekend as multiple companies showed off mid- and late-stage assets that could change the way some patients are treated for their cancer. This morning, BioSpace takes a look at some of the announcements.

October 22, 2018
·
5 min read
·
Alex Keown